Market closed
Procaps Group/$PROC
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Procaps Group
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
Ticker
$PROC
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Luxembourg, Luxembourg
Employees
5,500
Website
Procaps Group Metrics
BasicAdvanced
$283M
Market cap
4.89
P/E ratio
$0.51
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$283M
52-week high
$4.95
52-week low
$0.50
Average daily volume
191K
Financial strength
Current ratio
1.47
Quick ratio
0.929
Long term debt to equity
573.886
Total debt to equity
753.94
Interest coverage (TTM)
1.28%
Management effectiveness
Return on assets (TTM)
6.28%
Return on equity (TTM)
373.70%
Valuation
Price to earnings (TTM)
4.894
Price to revenue (TTM)
0.616
Price to book
6.53
Price to tangible book (TTM)
-33.31
Price to free cash flow (TTM)
7.49
Growth
Revenue change (TTM)
-4.80%
Earnings per share change (TTM)
-13.40%
What the Analysts think about Procaps Group
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Procaps Group stock.
Procaps Group Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Procaps Group Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Procaps Group News
AllArticlesVideos
Procaps Group Announces Key Shareholder and Board Decisions, Committee Restructuring, and Leadership Updates
GlobeNewsWire·1 day ago
Procaps Group Announces Financing, Shareholders Agreement and Board Updates
GlobeNewsWire·3 weeks ago
Procaps Receives Nasdaq Listing Determination; To Request Hearing and Further Stay Pending Hearing
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Procaps Group stock?
Procaps Group (PROC) has a market cap of $283M as of December 22, 2024.
What is the P/E ratio for Procaps Group stock?
The price to earnings (P/E) ratio for Procaps Group (PROC) stock is 4.89 as of December 22, 2024.
Does Procaps Group stock pay dividends?
No, Procaps Group (PROC) stock does not pay dividends to its shareholders as of December 22, 2024.
When is the next Procaps Group dividend payment date?
Procaps Group (PROC) stock does not pay dividends to its shareholders.
What is the beta indicator for Procaps Group?
Procaps Group (PROC) does not currently have a Beta indicator.